Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,028,023
-$448,713 QoQ
Shares Held
840,572
+0.5% QoQ
Ownership
0.592%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. TRVI ranks #98 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,028,023 840,572
2025-12-31 $10,476,736 836,800
2025-09-30 $7,377,928 806,331
2025-06-30 $1,235,864 225,935
2025-03-31 $1,305,288 207,518
2024-12-31 $713,019 173,063
2024-09-30 $504,066 150,918
2024-06-30 $449,735 150,918
2024-03-31 $371,589 107,707
2023-12-31 $144,327 107,707
2023-09-30 $234,801 107,707
2023-06-30 $257,419 107,707
2023-03-31 $23,230 12,557
2022-12-31 $24,235 12,557
2022-09-30 $19,337 12,557
2022-06-30 $35,285 12,557